The Inspirational Quest to Eradicate Cancer

The world-renowned Thoracic Oncologist, Dr. Gerold Bepler, joined I Don’t Care’s Kevin Stevenson for a conversation that was no less than inspirational. Dr. Bepler, President and CEO of the Karmanos Cancer Institute, has a mission; to eradicate cancer. It’s more than a dream for Dr. Bepler; he believes it will be a reality one day.

Dr. Bepler arrived from Germany to the United States in 1983. Following a post-doctoral fellowship at the National Cancer Institute, the starting point for his journey into lung cancer research. This career path took Dr. Bepler through many stops along the way, and in 2010 he joined the Karmanos Cancer Institute.

The mission to eradicate cancer got a boost in 1971 with the National Cancer Act, and Dr. Bepler said there’s tremendous progress towards this goal since that point. “People now diagnosed with cancer have hope,” Dr. Bepler said. “And many of them get cured of the disease and have a good quality of life. That all wouldn’t have been possible without the National Cancer Act.”

Much of the progress made to eradicating cancer at the Karmanos Cancer Institute owes a debt of gratitude to that 50-year-old law for providing necessary funding that makes such research possible.

“The Karmanos Cancer Institute became one of the NCI designated cancer centers,” Dr. Bepler said. “Very quickly, the National Cancer Institute realized just having one cancer institute in Bethesda, Maryland alone wouldn’t be able to achieve that high goal of eradicating cancer. This network established cancer centers throughout the United States.” What started as a couple of centers in the 1970s is now more than 50 comprehensive cancer centers.

The world now possesses many drugs and treatments to treat cancer through the dedication and research of institutes like the Karmanos Center. And some research led to treatments for other diseases. Dr. Bepler mentioned the Karmanos Center developed three of the first FDA-approved AIDS drugs.

More Like This Story:

The Rising Tide of Food Allergens

From an Idea to Billion Dollar Company: How a Doctor Lobbied DC for HSAs

Follow us on social media for the latest updates in B2B!

Image

Latest

AI data center
Power, Cooling, and Risk: What It Takes to Bring a 100MW AI Data Center Online
March 28, 2026

The industry knows how to build data centers. What it’s still figuring out is how to turn on AI factories at scale. With facilities now crossing 100 megawatts—far beyond the 5 to 10 megawatt norm of traditional builds—operators are no longer just validating equipment. They’re testing whether entire systems—power, cooling, controls, and the teams behind…

Read More
beauty
Building Beauty for Real Women: Why Brands Must Focus on Longevity, Not Hype
March 25, 2026

Walk into any beauty aisle—or scroll through your feed for five minutes—and it’s clear the industry is obsessed with what’s new. New formulas, new trends, new “rules.” But for many women, especially those who’ve been using makeup for decades, the question isn’t what’s new—it’s what actually works. And increasingly, the answer isn’t coming from the…

Read More
Physician
Fixing the Physician Experience: Why Advocacy Is Healthcare’s Next Frontier
March 25, 2026

Physician burnout has become a defining challenge in healthcare, with research showing that a substantial portion of clinicians—anywhere from roughly a quarter to over half—experience emotional exhaustion, driven more by systemic pressures like administrative burden and reduced autonomy than by individual resilience alone. As healthcare systems face growing staffing shortages and rising patient demand, the…

Read More
career
From Starting Over In A New Country To Reaching The C-Suite: A CFO’s Career Comeback
March 25, 2026

Global mobility is reshaping the modern workforce, with millions of professionals relocating each year in pursuit of opportunity, stability, or growth. Yet behind the headlines of talent migration lies a quieter, more difficult truth: restarting a career from scratch—even after years of success—is far more common than people expect. In fact, many skilled immigrants…

Read More